Company · CIK 1822462

# Foghorn Therapeutics Inc.

| CIK | [1822462](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001822462) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | FHTX (Nasdaq) |
| First annual or quarterly report | 2020-12-04 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-284476 | Shelf Effective | 2025-01-24 | 2026-01-12 | 4 |
| 333-262711 | Shelf Effective | 2022-02-14 | 2024-08-08 | 6 |
| 333-249264 | IPO Final prospectus | 2020-10-02 | 2020-10-26 | 6 |

## Filings

 17

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-01-12 | [424B5](https://www.sec.gov/Archives/edgar/data/1822462/000119312526010520/0001193125-26-010520-index.htm) Shelf takedown | 333-284476 | 0001193125-26-010520 |
| 2025-03-20 | [424B5](https://www.sec.gov/Archives/edgar/data/1822462/000162828025014133/0001628280-25-014133-index.htm) Shelf takedown | 333-284476 | 0001628280-25-014133 |
| 2025-01-31 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1822462/999999999525000278/9999999995-25-000278-index.htm) Declared effective | 333-284476 | 9999999995-25-000278 |
| 2025-01-24 | [S-3](https://www.sec.gov/Archives/edgar/data/1822462/000162828025002469/0001628280-25-002469-index.htm) Shelf registered | 333-284476 | 0001628280-25-002469 |
| 2024-08-08 | [424B5](https://www.sec.gov/Archives/edgar/data/1822462/000119312524196520/0001193125-24-196520-index.htm) Shelf takedown | 333-262711 | 0001193125-24-196520 |
| 2024-05-20 | [424B5](https://www.sec.gov/Archives/edgar/data/1822462/000119312524142887/0001193125-24-142887-index.htm) Shelf takedown | 333-262711 | 0001193125-24-142887 |
| 2022-04-19 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1822462/999999999522001023/9999999995-22-001023-index.htm) Declared effective | 333-262711 | 9999999995-22-001023 |
| 2022-04-15 | [424B5](https://www.sec.gov/Archives/edgar/data/1822462/000119312522106802/0001193125-22-106802-index.htm) Shelf takedown | 333-262711 | 0001193125-22-106802 |
| 2022-03-14 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1822462/999999999522000629/9999999995-22-000629-index.htm) Declared effective | 333-262711 | 9999999995-22-000629 |
| 2022-02-14 | [S-3](https://www.sec.gov/Archives/edgar/data/1822462/000162828022002520/0001628280-22-002520-index.htm) Shelf registered | 333-262711 | 0001628280-22-002520 |
| 2020-10-26 | [424B4](https://www.sec.gov/Archives/edgar/data/1822462/000119312520276924/0001193125-20-276924-index.htm) Final prospectus | 333-249264 | 0001193125-20-276924 |
| 2020-10-23 | [424B4](https://www.sec.gov/Archives/edgar/data/1822462/000119312520275426/0001193125-20-275426-index.htm) Final prospectus | 333-249264 | 0001193125-20-275426 |
| 2020-10-22 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1822462/999999999520002949/9999999995-20-002949-index.htm) Declared effective | 333-249264 | 9999999995-20-002949 |
| 2020-10-22 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1822462/000119312520274108/0001193125-20-274108-index.htm) Amendment | 333-249264 | 0001193125-20-274108 |
| 2020-10-19 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1822462/000119312520271564/0001193125-20-271564-index.htm) Amendment | 333-249264 | 0001193125-20-271564 |
| 2020-10-02 | [S-1](https://www.sec.gov/Archives/edgar/data/1822462/000119312520262469/0001193125-20-262469-index.htm) Registration filed | 333-249264 | 0001193125-20-262469 |
| 2020-08-28 | [DRS](https://www.sec.gov/Archives/edgar/data/1822462/000095012320009426/0000950123-20-009426-index.htm) Draft made public | 377-03473 | 0000950123-20-009426 |

[All filings of this company](https://equitycapital.markets/filings?cik=1822462) · [CSV](https://equitycapital.markets/filings.csv?cik=1822462)

---
Source page: https://equitycapital.markets/company/1822462 · Data: U.S. SEC EDGAR · CC BY 4.0